Literature DB >> 2833855

Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides.

H Youssoufian1, S E Antonarakis, W Bell, A M Griffin, H H Kazazian.   

Abstract

Hemophilia A is an X-linked disease of coagulation caused by deficiency of factor VIII. Using cloned cDNA and synthetic oligonucleotide probes, we have now screened 240 patients and found CG-to-TG transitions in an exon in nine. We have previously reported four of these patients; and here we report the remaining five, all of whom were severely affected. In one patient a TaqI site was lost in exon 23, and in the other four it was lost in exon 24. The novel exon 23 mutation is a CG-to-TG substitution at the codon for amino acid residue 2166, producing a nonsense codon in place of the normal codon for arginine. Similarly, the exon 24 mutations are also generated by CG-to-TG transitions, either on the sense strand producing nonsense mutations or on the antisense strand producing missense mutations (Arg to Gln) at position 2228. The novel missense mutations are the first such mutations observed in association with severe hemophilia A. These results provide further evidence that recurrent mutations are not uncommon in hemophilia A, and they also allow us to estimate that the extent of hypermutability of CG dinucleotides is 10-20 times greater than the average mutation rate for hemophilia A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833855      PMCID: PMC1715175     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  Letter: A more uniform measurement of factor VIII inhibitors.

Authors: 
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

2.  Molecular basis of base substitution hotspots in Escherichia coli.

Authors:  C Coulondre; J H Miller; P J Farabaugh; W Gilbert
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

3.  Eukaryotic dinucleotide preference rules and their implications for degenerate codon usage.

Authors:  R Nussinov
Journal:  J Mol Biol       Date:  1981-06-15       Impact factor: 5.469

4.  DNA methylation and the frequency of CpG in animal DNA.

Authors:  A P Bird
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

Review 5.  Molecular genetics of hemophilia A in man (factor VIII deficiency).

Authors:  S E Antonarakis; H Youssoufian; H H Kazazian
Journal:  Mol Biol Med       Date:  1987-04

6.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.

Authors:  D Barker; M Schafer; R White
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

7.  DNA methylation: organ specific variations in the methylation pattern within and around ovalbumin and other chicken genes.

Authors:  J L Mandel; P Chambon
Journal:  Nucleic Acids Res       Date:  1979-12-20       Impact factor: 16.971

8.  Immunoradiometric measurement of the factor VIII procoagulant antigen.

Authors:  J Lazarchick; L W Hoyer
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene.

Authors:  V J Kidd; R B Wallace; K Itakura; S L Woo
Journal:  Nature       Date:  1983 Jul 21-27       Impact factor: 49.962

10.  The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA.

Authors:  R B Wallace; M J Johnson; T Hirose; T Miyake; E H Kawashima; K Itakura
Journal:  Nucleic Acids Res       Date:  1981-02-25       Impact factor: 16.971

View more
  41 in total

1.  Identical point mutations in the factor VIII gene that have different clinical manifestations of hemophilia A.

Authors:  R Schwaab; M Ludwig; J Oldenburg; H H Brackmann; H Egli; L Kochhan; K Olek
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

2.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

3.  Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the disease.

Authors:  M H Delfau; C Picat; F De Rooij; G Voortman; J C Deybach; Y Nordmann; B Grandchamp
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

4.  The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

5.  Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis.

Authors:  M Higuchi; S E Antonarakis; L Kasch; J Oldenburg; E Economou-Petersen; K Olek; M Arai; H Inaba; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

Authors:  J Rae; P E Newburger; M C Dinauer; D Noack; P J Hopkins; R Kuruto; J T Curnutte
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

7.  Investigation of factor VIII:C gene restriction fragment length polymorphisms and search for deletions in hemophiliac subjects in Algeria.

Authors:  K Nafa; F Meriane; A Reghis; M Benabadji; F Demenais; M Guilloud-Bataille; Y Sultan; J C Kaplan; M Delpech
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

8.  Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs.

Authors:  D D Koeberl; C D Bottema; G Sarkar; R P Ketterling; S H Chen; S S Sommer
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

9.  The molecular genetics of haemophilia A: screening for point mutations in the factor VIII gene using the restriction enzyme TaqI.

Authors:  D S Millar; B Zoll; U Martinowitz; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

10.  Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies.

Authors:  J Becker; R Schwaab; A Möller-Taube; U Schwaab; W Schmidt; H H Brackmann; T Grimm; K Olek; J Oldenburg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.